145 related articles for article (PubMed ID: 25701380)
1. Drugs and Diseases Interacting with Cigarette Smoking in US Prescription Drug Labelling.
Li H; Shi Q
Clin Pharmacokinet; 2015 May; 54(5):493-501. PubMed ID: 25701380
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of cigarette warning labels in informing smokers about the risks of smoking: findings from the International Tobacco Control (ITC) Four Country Survey.
Hammond D; Fong GT; McNeill A; Borland R; Cummings KM
Tob Control; 2006 Jun; 15 Suppl 3(Suppl 3):iii19-25. PubMed ID: 16754942
[TBL] [Abstract][Full Text] [Related]
3. The need for contraception in patients taking prescription drugs: a review of FDA warning labels, duration of effects, and mechanisms of action.
Zhang Z; Xu L; Zhang Z; Ding H; Rayburn ER; Li H
Expert Opin Drug Saf; 2018 Dec; 17(12):1171-1183. PubMed ID: 30394114
[No Abstract] [Full Text] [Related]
4. An appraisal of potential drug interactions in cigarette smokers and alcohol drinkers.
Smith RG
J Am Podiatr Med Assoc; 2009; 99(1):81-8. PubMed ID: 19141727
[TBL] [Abstract][Full Text] [Related]
5. Risk management policy and black-box warnings: a qualitative analysis of US FDA proceedings.
Cook DM; Gurugubelli RK; Bero LA
Drug Saf; 2009; 32(11):1057-66. PubMed ID: 19810777
[TBL] [Abstract][Full Text] [Related]
6. Impact of FDA Actions, DTCA, and Public Information on the Market for Pain Medication.
Bradford WD; Kleit AN
Health Econ; 2015 Jul; 24(7):859-75. PubMed ID: 25059655
[TBL] [Abstract][Full Text] [Related]
7. Young adults' perceptions of cigarette warning labels in the United States and Canada.
O'Hegarty M; Pederson LL; Yenokyan G; Nelson D; Wortley P
Prev Chronic Dis; 2007 Apr; 4(2):A27. PubMed ID: 17362618
[TBL] [Abstract][Full Text] [Related]
8. FDA-approved drugs that interfere with laboratory tests: A systematic search of US drug labels.
Yao H; Rayburn ER; Shi Q; Gao L; Hu W; Li H
Crit Rev Clin Lab Sci; 2017 Jan; 54(1):1-17. PubMed ID: 27193822
[TBL] [Abstract][Full Text] [Related]
9. Contraindication labelling changes in the United States and Germany.
Garbe E; Andersohn F
Eur J Clin Pharmacol; 2007 Jan; 63(1):87-93. PubMed ID: 17124576
[TBL] [Abstract][Full Text] [Related]
10. No sisyphean task: how the FDA can regulate electronic cigarettes.
Paradise J
Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
[TBL] [Abstract][Full Text] [Related]
11. Testing warning messages on smokers' cigarette packages: a standardised protocol.
Brewer NT; Hall MG; Lee JG; Peebles K; Noar SM; Ribisl KM
Tob Control; 2016 Mar; 25(2):153-9. PubMed ID: 25564282
[TBL] [Abstract][Full Text] [Related]
12. The impact and acceptability of Canadian-style cigarette warning labels among U.S. smokers and nonsmokers.
Peters E; Romer D; Slovic P; Jamieson KH; Wharfield L; Mertz CK; Carpenter SM
Nicotine Tob Res; 2007 Apr; 9(4):473-81. PubMed ID: 17454702
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics.
Miller LG
Clin Pharmacokinet; 1989 Aug; 17(2):90-108. PubMed ID: 2673608
[TBL] [Abstract][Full Text] [Related]
14. The Case for Requiring Graphic Warning Labels on Smokeless Tobacco Product Packages.
Pakhale S; Samet J; Folan P; Leone F; White A;
Ann Am Thorac Soc; 2016 Mar; 13(3):329-33. PubMed ID: 26784741
[TBL] [Abstract][Full Text] [Related]
15. Public support for graphic health warning labels in the U.S.
Kamyab K; Nonnemaker JM; Farrelly MC
Am J Prev Med; 2015 Jan; 48(1):89-92. PubMed ID: 25217818
[TBL] [Abstract][Full Text] [Related]
16. The Importance of Clinical Research in Pregnant Women to Inform Prescription Drug Labeling.
Dinatale M; Roca C; Sahin L; Johnson T; Mulugeta LY; Fletcher EP; Yao L
J Clin Pharmacol; 2020 Dec; 60 Suppl 2():S18-S25. PubMed ID: 33274508
[TBL] [Abstract][Full Text] [Related]
17. Identifying principles for effective messages about chemicals in cigarette smoke.
Noar SM; Kelley DE; Boynton MH; Morgan JC; Hall MG; Mendel JR; Ribisl KM; Brewer NT
Prev Med; 2018 Jan; 106():31-37. PubMed ID: 28890353
[TBL] [Abstract][Full Text] [Related]
18. Proposed US Food and Drug Administration guidance for industry on distributing medical publications about the risks of prescription drugs and biological products: a misguided approach.
Wolfe SM
JAMA Intern Med; 2014 Oct; 174(10):1543-4. PubMed ID: 25127222
[No Abstract] [Full Text] [Related]
19. Do the ends justify the means? A test of alternatives to the FDA proposed cigarette warning labels.
Byrne S; Katz SJ; Mathios A; Niederdeppe J
Health Commun; 2015; 30(7):680-93. PubMed ID: 25119144
[TBL] [Abstract][Full Text] [Related]
20. Permissive nicotine regulation as a complement to traditional tobacco control.
Sumner W
BMC Public Health; 2005 Feb; 5():18. PubMed ID: 15730554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
